Author

Nawaf Alanazi

King Abdulaziz HospitalORCID 0009-0004-2255-1193Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:whole-exome sequencing· 2 Assay:DNA methylation· 1

Frequent Co-Authors

Abdulaziz Siyal· 2 shared Amer MahmoodiD· 2 shared Masood A. ShammasiD· 2 shared Sarah AlMukhaylidiD· 2 shared Zafar IqbaliD· 2 shared Aamer AleemiD· 1 shared Muhammad M. AbsariD· 1 shared SALMAN ABDUL BASIT· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Abdulaziz Siyal

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintMar 9, 2024

A retrospective case-control study for Clinical Validation of mutated ZNF208 as a novel biomarker of fatal blast crisis in Chronic Myeloid Leukemia

Nawaf Alanazi, Abdulaziz Siyal, SALMAN ABDUL BASIT…·Zafar Iqbal

This study validates ZNF208 mutation (c.64G>A) as a specific biomarker for advanced phase CML through targeted resequencing in a case-control cohort.

DOI 10.1101/2024.03.09.24304026

humanDNA methylation

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintDec 19, 2023

Utilization of targeted resequencing for clinical validation of mutated FANCD2 gene as a promising molecular biomarker of early disease progression in Chronic Myeloid Leukemia

Nawaf Alanazi, Abdulaziz Siyal, Muhammad M. Absar…·Zafar Iqbal

This study identifies a FANCD2 mutation as a specific biomarker for early progression in Chronic Myeloid Leukemia using targeted resequencing and NGS analysis.

DOI 10.1101/2023.12.19.23300103

humanwhole-exome sequencing

𝕏 PostBluesky